1530.HK Overview

Company Profile

Related stocks

300122.SZ • China

ZHIFEI-BIOL

13.7 CNY

4.91B USD 1Y -34.6%

688336.SS • China

SUNSHINE GUOJIAN PHARMACEUTICAL

38.1 CNY

5.11B USD 1Y +4.2%

9995.HK • China

REMEGEN

70.4 HKD

5.34B USD 1Y -33.7%

002252.SZ • China

SHANGHAI RAAS

5.06 CNY

4.99B USD 1Y -25.4%

688180.SS • China

SHANGHAI JUNSHI BIOSCIENCES CO

33.83 CNY

5.19B USD 1Y -17.6%

002007.SZ • China

HUALAN BIO.

13.35 CNY

3.65B USD 1Y -17.6%

2696.HK • China

HENLIUS

50.75 HKD

3.53B USD 1Y -33%

688428.SS • China

INNOCARE PHARMA LTD

28.12 CNY

7.44B USD 1Y +5.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

53.7% p.a.

Max Drawdown (5Y)

-58.3%

Sharpe Ratio (5Y)

0.24

Beta Factor

0.40

Size Class

Large Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Elevated Short-Term Volatility: 3Y volatility (61.3%) is noticeably higher than the 5Y average (53.7%).

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (53.7% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -78.7% in the extended horizon.